JP2019500902A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019500902A5 JP2019500902A5 JP2018553039A JP2018553039A JP2019500902A5 JP 2019500902 A5 JP2019500902 A5 JP 2019500902A5 JP 2018553039 A JP2018553039 A JP 2018553039A JP 2018553039 A JP2018553039 A JP 2018553039A JP 2019500902 A5 JP2019500902 A5 JP 2019500902A5
- Authority
- JP
- Japan
- Prior art keywords
- morpholino oligomer
- antisense morpholino
- formula
- cpp
- antisense
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562387178P | 2015-12-23 | 2015-12-23 | |
| US62/387,178 | 2015-12-23 | ||
| PCT/US2016/068376 WO2017112888A1 (en) | 2015-12-23 | 2016-12-22 | Antisense antibacterial compounds and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019500902A JP2019500902A (ja) | 2019-01-17 |
| JP2019500902A5 true JP2019500902A5 (https=) | 2020-02-06 |
| JP7393121B2 JP7393121B2 (ja) | 2023-12-06 |
Family
ID=59091240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018553039A Active JP7393121B2 (ja) | 2015-12-23 | 2016-12-22 | アンチセンス抗菌化合物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11142764B2 (https=) |
| EP (1) | EP3394262B1 (https=) |
| JP (1) | JP7393121B2 (https=) |
| AU (1) | AU2016379402B2 (https=) |
| CA (1) | CA3009342A1 (https=) |
| WO (1) | WO2017112888A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9790495B2 (en) | 2014-05-16 | 2017-10-17 | Oregon State University | Antisense antibacterial compounds and methods |
| AU2015264449B2 (en) | 2014-05-19 | 2022-05-05 | Board Of Regents, The University Of Texas System | Antisense antibacterial compounds and methods |
| CA3249464A1 (en) | 2014-12-31 | 2025-11-29 | Univ Texas | Antisense antibacterial compounds and methods |
| AU2016379399B2 (en) | 2015-12-23 | 2022-12-08 | Board Of Regents, The University Of Texas System | Antisense antibacterial compounds and methods |
| GB2579253A (en) | 2018-11-28 | 2020-06-17 | Pedanius Therapeutics Ltd | Antibacterial antisense agents |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US5217866A (en) | 1985-03-15 | 1993-06-08 | Anti-Gene Development Group | Polynucleotide assay reagent and method |
| US5506337A (en) | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
| US5521063A (en) | 1985-03-15 | 1996-05-28 | Antivirals Inc. | Polynucleotide reagent containing chiral subunits and methods of use |
| US5185444A (en) | 1985-03-15 | 1993-02-09 | Anti-Gene Deveopment Group | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
| US5166315A (en) | 1989-12-20 | 1992-11-24 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
| JP3022967B2 (ja) | 1985-03-15 | 2000-03-21 | アンチバイラルズ インコーポレイテッド | 立体規則性ポリヌクレオチド結合ポリマー |
| WO1993001286A2 (en) | 1991-06-28 | 1993-01-21 | Massachusetts Institute Of Technology | Localized oligonucleotide therapy |
| ATE330644T1 (de) | 1995-12-18 | 2006-07-15 | Angiotech Biomaterials Corp | Vernetzten polymerisatmassen und verfahren für ihre verwendung |
| US6245747B1 (en) | 1996-03-12 | 2001-06-12 | The Board Of Regents Of The University Of Nebraska | Targeted site specific antisense oligodeoxynucleotide delivery method |
| KR20020064915A (ko) | 1999-11-29 | 2002-08-10 | 에이브이아이 바이오파마 인코포레이티드 | 안티센스 항박테리아 방법 및 조성물 |
| US6965025B2 (en) | 2001-12-10 | 2005-11-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of connective tissue growth factor expression |
| CA2523672C (en) | 2003-04-29 | 2012-07-17 | Avi Biopharma, Inc. | Compositions for enhancing transport of molecules into cells |
| CA2614191C (en) | 2005-07-13 | 2015-06-30 | Avi Biopharma, Inc. | Antisense antibacterial method and compound |
| US8067571B2 (en) * | 2005-07-13 | 2011-11-29 | Avi Biopharma, Inc. | Antibacterial antisense oligonucleotide and method |
| US20100016215A1 (en) | 2007-06-29 | 2010-01-21 | Avi Biopharma, Inc. | Compound and method for treating myotonic dystrophy |
| EP3443976A1 (en) * | 2007-06-29 | 2019-02-20 | Sarepta Therapeutics, Inc. | Tissue specific peptide conjugates and methods |
| US8299206B2 (en) | 2007-11-15 | 2012-10-30 | Avi Biopharma, Inc. | Method of synthesis of morpholino oligomers |
| MX2010004955A (es) | 2007-11-15 | 2010-06-30 | Avi Biopharma Inc | Metodo de sintesis de oligomeros de morfolina. |
| US8076476B2 (en) | 2007-11-15 | 2011-12-13 | Avi Biopharma, Inc. | Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits |
| US20110269665A1 (en) * | 2009-06-26 | 2011-11-03 | Avi Biopharma, Inc. | Compound and method for treating myotonic dystrophy |
| WO2012031243A2 (en) | 2010-09-03 | 2012-03-08 | Avi Biopharma, Inc. | dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS |
| RS55610B1 (sr) | 2010-09-30 | 2017-06-30 | Nippon Shinyaku Co Ltd | Derivat morfolino nukleinske kiseline |
| WO2012150960A1 (en) | 2011-05-05 | 2012-11-08 | Avi Biopharma, Inc. | Peptide oligonucleotide conjugates |
| US9790495B2 (en) * | 2014-05-16 | 2017-10-17 | Oregon State University | Antisense antibacterial compounds and methods |
| AU2015264449B2 (en) | 2014-05-19 | 2022-05-05 | Board Of Regents, The University Of Texas System | Antisense antibacterial compounds and methods |
| CA3249464A1 (en) | 2014-12-31 | 2025-11-29 | Univ Texas | Antisense antibacterial compounds and methods |
| AU2016379399B2 (en) | 2015-12-23 | 2022-12-08 | Board Of Regents, The University Of Texas System | Antisense antibacterial compounds and methods |
| WO2019083823A1 (en) | 2017-10-23 | 2019-05-02 | Board Of Regents, The University Of Texas System | ANTISENSE ANTIBACTERIAL COMPOUNDS AND ASSOCIATED METHODS |
-
2016
- 2016-12-22 AU AU2016379402A patent/AU2016379402B2/en active Active
- 2016-12-22 CA CA3009342A patent/CA3009342A1/en active Pending
- 2016-12-22 WO PCT/US2016/068376 patent/WO2017112888A1/en not_active Ceased
- 2016-12-22 US US16/064,306 patent/US11142764B2/en active Active
- 2016-12-22 EP EP16880107.4A patent/EP3394262B1/en active Active
- 2016-12-22 JP JP2018553039A patent/JP7393121B2/ja active Active
-
2021
- 2021-10-12 US US17/498,880 patent/US12209240B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019500902A5 (https=) | ||
| JP2017522004A5 (https=) | ||
| JP2017522044A5 (https=) | ||
| JP7049262B2 (ja) | 結合組織成長因子を標的とするｒｎａ複合体を用いた特発性肺胞線維症の治療 | |
| JP2017505623A5 (https=) | ||
| EP3143141B1 (en) | Antisense antibacterial compounds and methods | |
| US20220073914A1 (en) | Compounds and methods for modulation of smn2 | |
| Lee et al. | Antisense peptide nucleic acids as a potential anti-infective agent | |
| JP6687542B2 (ja) | アンチセンス抗菌化合物および方法 | |
| WO2019233922A1 (en) | Oligonucleotides for modulating atxn2 expression | |
| JP2019506862A (ja) | Ａｎｇｐｔ２およびｐｄｇｆｂを標的化するｒｎａ複合体を用いる血管新生関連疾患の処置 | |
| EA031110B1 (ru) | Конъюгаты бороновых кислот олигонуклеотидных аналогов | |
| JP2014532400A (ja) | 免疫賦活用の二本鎖ｒｎａ | |
| JP7393121B2 (ja) | アンチセンス抗菌化合物および方法 | |
| WO2017068791A1 (ja) | 少なくとも１つのバルジ構造を有する核酸複合体 | |
| JP7737667B2 (ja) | 核酸複合体 | |
| EP3947677A1 (en) | Oligonucleotides for modulating atxn2 expression | |
| US20190345496A1 (en) | Antisense oligonucleotides for modulating relb expression | |
| US20190345495A1 (en) | Antisense oligonucleotides for modulating nfkb2 expression | |
| WO2020136125A2 (en) | Antisense oligonucleotides targeting card9 | |
| WO2020038973A1 (en) | Antisense oligonucleotides targeting sptlc1 | |
| US20190367920A1 (en) | Antisense oligonucleotides for modulating nfkb1 expression | |
| US20200216845A1 (en) | Antisense oligonucleotides for modulating rela expression | |
| WO2020038976A1 (en) | Antisense oligonucleotides targeting usp8 | |
| US20190338286A1 (en) | Antisense oligonucleotides for modulating rel expression |